Invasive Pulmonary Aspergillosis
29
4
5
12
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
6.9%
2 terminated out of 29 trials
85.7%
-0.8% vs benchmark
21%
6 trials in Phase 3/4
33%
4 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (29)
Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors
Influenza A-associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit in China
PCR for Aspergillus Fumigatus in Blood and Bronchoalveolar Lavage Fluid for Monitoring Cases of Invasive Aspergillosis: What is Its Prognostic Value
Influenza Associated Aspergillosis In-depth Investigation
Breath Analysis for the Detection of Invasive Fungal Infections
Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis
Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment
Assessing Diagnostic Methods for Invasive Fungal Disease in Lung Transplant Recipients
Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary Aspergillosis
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
Early Diagnosis of Invasive Lung Aspergillosis
VOC in Breath Samples for the Diagnosis of IPA
Prevalence of Influenza RelAted Invasive Aspergillosis
Nebulised Liposomal Amphotericin for Invasive Pulmonary Aspergillosis (NAIFI01 Study)
Non-invasive Tools to Diagnose Invasive Aspergillosis Infections in ICU Patients With COVID-19 and Other Conditions.
LFD of Aspergillus Antigen in Paediatrics
Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis: a Multicenter Study
Diagnosis of Invasive Pulmonary Aspergillosis, Specific Testing in Bronchial Secretions Versus Bronchoalveolar Fluid
Clinical and Prognostic Comparisons Between Invasive Pulmonary Aspergillosis With or Without Invasive Tracheobronchitis During Severe Influenza: a Retrospective Multicenter Cohort Study.
VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults